Taking a plunge into the healthcare sector when it’s fighting with a huge image problem requires courage. Moreover, when the investment product targets the biotech sector – which recently witnessed a big sell-off amid a raging drug-pricing controversy, questions are bound to be raised about the timing. But for Brad Loncar, the Kansas based former budget manager in the international …
Tag Archive
Below you'll find a list of all posts that have been tagged as “CNCR”